HUP9900492A2 - 3,6-Ketál és enol-éter makrolid antibiotikumok és ezeket tartalmazó gyógyszerkészítmények - Google Patents

3,6-Ketál és enol-éter makrolid antibiotikumok és ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP9900492A2
HUP9900492A2 HU9900492A HUP9900492A HUP9900492A2 HU P9900492 A2 HUP9900492 A2 HU P9900492A2 HU 9900492 A HU9900492 A HU 9900492A HU P9900492 A HUP9900492 A HU P9900492A HU P9900492 A2 HUP9900492 A2 HU P9900492A2
Authority
HU
Hungary
Prior art keywords
contg
ketal
pharmaceuticals
enol ether
macrolide antibiotics
Prior art date
Application number
HU9900492A
Other languages
English (en)
Inventor
Peter Bertinato
Hengmiao Cheng
Kristin M. Lundy
Martha L. Minich
Subas M. Sakya
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of HU9900492D0 publication Critical patent/HU9900492D0/hu
Publication of HUP9900492A2 publication Critical patent/HUP9900492A2/hu
Publication of HUP9900492A3 publication Critical patent/HUP9900492A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

A találmány tárgya (1) vagy (2) általánős képletű vegyület, melyalkalmas baktériűm, parazita vagy prőtőzőőn őkőzta fertőzések,valamint baktériűm, parazita vagy prőtőzőőn őkőzta fertőzésselkapcsőlatős betegségek kezelésére emlősöknél, halaknál és madaraknál.A találmány tővábbi tárgyát képezik az (1) vagy (2) általánős képletűvegyületet tartalmaz gyógyszerkészítmények is. ŕ
HU9900492A 1998-03-03 1999-03-02 3,6-ketal and enol ether macrolide antibiotics and pharmaceuticals contg. them HUP9900492A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7663098P 1998-03-03 1998-03-03

Publications (3)

Publication Number Publication Date
HU9900492D0 HU9900492D0 (en) 1999-04-28
HUP9900492A2 true HUP9900492A2 (hu) 1999-09-28
HUP9900492A3 HUP9900492A3 (en) 2001-08-28

Family

ID=22133253

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900492A HUP9900492A3 (en) 1998-03-03 1999-03-02 3,6-ketal and enol ether macrolide antibiotics and pharmaceuticals contg. them

Country Status (17)

Country Link
US (1) US6043226A (hu)
EP (1) EP0941998B1 (hu)
JP (1) JP3666788B2 (hu)
CN (1) CN1244532A (hu)
AR (1) AR016715A1 (hu)
AT (1) ATE275151T1 (hu)
AU (1) AU741435B2 (hu)
BR (1) BR9900856A (hu)
CA (1) CA2263203C (hu)
DE (1) DE69919769T2 (hu)
DK (1) DK0941998T3 (hu)
ES (1) ES2226282T3 (hu)
HU (1) HUP9900492A3 (hu)
NO (1) NO312366B1 (hu)
NZ (1) NZ334442A (hu)
PT (1) PT941998E (hu)
ZA (1) ZA991664B (hu)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HUP0104192A3 (en) 1998-11-03 2003-12-29 Pfizer Prod Inc Novel macrolide antibiotics
US6939861B2 (en) 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
US6451768B1 (en) * 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
WO2000063224A2 (en) 1999-04-16 2000-10-26 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6590083B1 (en) * 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6514944B2 (en) * 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
IL145739A0 (en) * 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
CA2428158C (en) * 2000-11-07 2010-06-29 Morphotek, Inc. Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
US8063021B2 (en) * 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
US20060141470A1 (en) * 2003-02-14 2006-06-29 Kalayoglu Murat V Chlamydia pneumoniae associated chronic intraocular disorders and treatment thereof
EA011281B1 (ru) * 2004-12-21 2009-02-27 Пфайзер Продактс Инк. Макролиды
US7517859B2 (en) * 2005-05-04 2009-04-14 Enanta Pharmaceuticals, Inc. Spirocyclic bicyclolides
EP2203435B1 (en) * 2007-09-17 2018-07-18 Enanta Pharmaceuticals, Inc. 6, 11-bridged biaryl macrolides
WO2018193126A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as antibacterial agents
GB201706299D0 (en) * 2017-04-20 2017-06-07 Novintum Biotechnology Gmbh Compounds
WO2018193111A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as anticancer agents
CN111148750A (zh) * 2017-04-20 2020-05-12 来兴泰德基金会 作为抗癌剂的包含鏻离子的阿奇霉素衍生物
US11560395B2 (en) 2017-04-20 2023-01-24 Rising Tide Foundation Azithromycin derivatives containing a phosphonium ion as anticancer agents
WO2018193116A1 (en) * 2017-04-20 2018-10-25 Novintum Biotechnology Gmbh Azithromycin derivatives containing a phosphonium ion as anticancer agents
US11229657B2 (en) 2017-04-21 2022-01-25 Lunella Biotech, Inc. Targeting hypoxic cancer stem cells (CSCs) with doxycycline: implications for improving anti-angiogenic therapy
US11197872B2 (en) 2017-04-21 2021-12-14 Lunella Biotech, Inc. Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs)
KR20200010343A (ko) 2017-05-19 2020-01-30 루넬라 바이오테크 인코포레이티드 안티미토신: 암 줄기 세포를 근절하기 위한 미토콘드리아 생물발생의 표적화 억제제
SG11201913134UA (en) 2017-06-26 2020-01-30 Lunella Biotech Inc Mitoketoscins: mitochondrial-based therapeutics targeting ketone metabolism in cancer cells
GB201817083D0 (en) * 2018-10-19 2018-12-05 Novintum Biotechnology Gmbh Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8721165D0 (en) * 1987-09-09 1987-10-14 Beecham Group Plc Chemical compounds
EP0344106A3 (de) * 1988-05-24 1990-01-31 Ciba-Geigy Ag Blaue Dispersionsfarbstoffe und Mischungen blauer Dispersionsfarbstoffe
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
US5602239A (en) * 1993-01-26 1997-02-11 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives
AU2340797A (en) * 1996-05-07 1997-11-26 Abbott Laboratories 6-o-substituted erythromycins and method for making them

Also Published As

Publication number Publication date
DK0941998T3 (da) 2004-09-20
AU741435B2 (en) 2001-11-29
NZ334442A (en) 2000-03-27
CA2263203C (en) 2002-09-03
NO991012D0 (no) 1999-03-02
NO312366B1 (no) 2002-04-29
AR016715A1 (es) 2001-07-25
HUP9900492A3 (en) 2001-08-28
DE69919769D1 (de) 2004-10-07
CN1244532A (zh) 2000-02-16
EP0941998B1 (en) 2004-09-01
HU9900492D0 (en) 1999-04-28
ATE275151T1 (de) 2004-09-15
ES2226282T3 (es) 2005-03-16
JPH11315093A (ja) 1999-11-16
DE69919769T2 (de) 2005-01-27
EP0941998A3 (en) 1999-10-06
US6043226A (en) 2000-03-28
AU1856299A (en) 1999-09-16
CA2263203A1 (en) 1999-09-03
JP3666788B2 (ja) 2005-06-29
NO991012L (no) 1999-09-06
EP0941998A2 (en) 1999-09-15
PT941998E (pt) 2004-12-31
ZA991664B (en) 2000-10-12
BR9900856A (pt) 2000-04-25

Similar Documents

Publication Publication Date Title
HUP9900492A2 (hu) 3,6-Ketál és enol-éter makrolid antibiotikumok és ezeket tartalmazó gyógyszerkészítmények
SE8202961D0 (sv) Cefalosporinderivat och forfarande for deras framstellning
WO2003077828A3 (en) Novel florfenicol-type antibiotics
RU95112465A (ru) Пирановые соединения, фармацевтическая композиция, способ получения и промежуточные соединения
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
NO834146L (no) Fremgangsmaate for fremstilling av epimert azahomoerytromycin a
RU95106362A (ru) Производные липопептида, способ их получения, содержащая их фармацевтическая композиция и способ ее получения
PT876388E (pt) Derivados de eritromicina triciclica
DK1037650T3 (da) Præparater til behandling af Staphylococcus aureus-infektioner
AR005642A1 (es) Compuestos antibioticos de cefalosporina, uso de los mismos para preparar composiciones farmaceuticas, dichas composiciones farmaceuticas que los comprenden,compuestos intermediarios de aplicacion en la preparacion de los primeros y metodo para elaborar dichos compuestos intermediarios
ATE143369T1 (de) Überbrückte, cyclische ketale
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
DK0824539T3 (da) Dialkyltiacumicin-forbindelser
EP0136830A3 (en) Azahomoerythromycin d derivative and intermediates therefor
DK1007530T3 (da) 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf
ES508985A0 (es) Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.
ES508984A0 (es) Procedimiento microbiologico para la obtencion de un nuevo compuesto antibiotico de la cepa streptomyces.
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
FI864537A (fi) Kefalosporinderivat och foerfarande foer deras framstaellning.
FI853506L (fi) Nya antibioter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner.
ES2038244T3 (es) Procedimiento para preparar un nuevo antibiotico, fumifungina, y su empleo como medicamento.
ATE240312T1 (de) Heterocyclische spiroderivate
IT1200422B (it) Composto con attivita' antimicrobia,sua preparazione e composizioni farmaceutiche che lo contengono
CA2013226A1 (en) Cephalosporin derivatives and processes for their preparation